Schizophrenia causes: Difference between revisions

Jump to navigation Jump to search
Line 63: Line 63:


|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Panic disorder]].
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Environmental]].
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Recurrent unexpected panic attacks. Excessive worry about additional [[panic attack]].  
* Recurrent unexpected panic attacks. Excessive worry about additional [[panic attack]].  

Revision as of 17:08, 9 March 2018

Schizophrenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Schizophrenia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Psychotherapy

Brain Stimulation Therapy

Social Impact

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Schizophrenia causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Schizophrenia causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Schizophrenia causes

CDC on Schizophrenia causes

Schizophrenia causes in the news

Blogs on Schizophrenia causes

Directions to Hospitals Treating Schizophrenia

Risk calculators and risk factors for Schizophrenia causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

Schizophrenia is a psychiatric diagnosis that describes a mental disorder characterized by impairments in the perception or expression of reality and by significant social or occupational dysfunction.

The causes of schizophrenia have been the subject of much debate over many decades with various factors proposed and discounted. To date none has been fully elucidated, but evidence suggests that genetic vulnerability and environmental stressors act in combination to result in schizophrenia.

Studies suggest that genetics, early environment, neurobiology and psychological and social processes are important contributory factors. Current psychiatric research into the development of the disorder often focuses on the role of neurobiology, although a reliable and identifiable organic cause has not been found. In the absence of a confirmed specific pathology underlying the diagnosis, some question the legitimacy of schizophrenia's status as a disease. Furthermore, some propose that the perceptions and feelings involved are meaningful and do not necessarily involve impairment. Although no common cause of schizophrenia has been identified in all individuals diagnosed with the condition, currently most researchers and clinicians believe it results from a combination of both brain vulnerabilities (either inherited or acquired) and stressful life-events. This widely-adopted approach is known as the 'stress-vulnerability' model, and much scientific debate now focuses on how much each of these factors contributes to the development and maintenance of schizophrenia.

It is also thought that processes in early neurodevelopment are important, particularly prenatal processes. In adult life, importance has been placed upon the function (or malfunction) of dopamine in the mesolimbic pathway in the brain. This theory, known as the dopamine hypothesis of schizophrenia largely resulted from the accidental finding that a drug group which blocks dopamine function, known as the phenothiazines, reduced psychotic symptoms. However, this theory is now thought to be overly simplistic as a complete explanation. These drugs have now been developed further and antipsychotic medication is commonly used as a first-line treatment. Although effective in many cases, these medications are not well tolerated by some patients due to significant side-effects. The positive symptoms are more responsive to medications; negative symptoms being less so.

Differences in brain structure have been found between people with schizophrenia and those without. However, these tend only to be reliable on the group level and, due to the significant variability between individuals, may not be reliably present in any particular individual. Significant brain atrophy and enlarged ventricles are the most conspicuous of such differences.

Causes

While the reliability of the schizophrenia diagnosis introduces difficulties in measuring the relative effect of genes and environment (for example, symptoms overlap to some extent with severe bipolar disorder or major depression), evidence suggests that genetic vulnerability and environmental stressors can act in combination to result in diagnosis of schizophrenia.[1]

The extent to which these factors influence the likelihood of being diagnosed with schizophrenia is debated widely, and currently, controversial. Schizophrenia is likely to be a diagnosis of complex inheritance. Thus, it is likely that several genes interact to generate risk for schizophrenia or for the separate components that can co-occur to lead to a diagnosis.[2] This, combined with disagreements over which research methods are best, or how data from genetic research should be interpreted, has led to differing estimates over genetic contribution.

It is thought that causal factors can initially come together in early neurodevelopment, including during pregnancy, to increase the risk of later developing schizophrenia. One curious finding is that people diagnosed with schizophrenia are more likely to have been born in winter or spring[3] (at least in the northern hemisphere). However, the effect is not large. Some researchers postulate that the correlation is due to viral infections during the third trimester (4–6 months) of pregnancy. There is now significant evidence that prenatal exposure to infections increases the risk for developing schizophrenia later in life, providing additional evidence for a link between in utero developmental pathology and risk of developing the condition.[4]


Schizophrenia is most commonly first diagnosed during late adolescence or early adulthood suggesting it is often the end process of childhood and adolescent development. Studies have indicated that genetic dispositions can interact with early environment to increase the risk of developing schizophrenia, including through global neurobehavioral deficits,[5] a poorer family environment and disruptive school behaviour,[6] poor peer engagement, immaturity or unpopularity[7] or poorer social competence and increasing schizophrenic symptomology emerging during adolescence[8] These developmental problems have also been linked to socioeconomic disadvantage or early experiences of traumatic events.[9]

There is on average a somewhat earlier onset for men than women, with the possible protective influence of the female hormone oestrogen being one hypothesis made and sociocultural influences another.

Causes of schizophrenia

Etiology Description
Genetic
  • Substantial evidence suggests that the diagnosis of schizophrenia has a heritable component (some estimates are as high as 80%). Current research suggests that environmental factors play a significant role in the expression of any genetic disposition towards schizophrenia (i.e. if someone has the genes that increase risk, this will not automatically result in a diagnosis of schizophrenia later in life).
  • A recent review of the genetic evidence has suggested a more than 28% chance of one identical twin obtaining the diagnosis if the other already has it[10] (see twin studies), but such studies are not noted for pondering the likelihood of similarities of social class and/or other socio-psychological factors between the twins.
  • The estimates of heritability of schizophrenia from twin studies varies a great deal, with some notable studies[11][12] showing rates as low as 11.0%–13.8% among monozygotic twins, and 1.8%–4.1% among dizygotic twins. However, some scientists criticize the methodology of the twin studies, and have argued that the genetic basis of schizophrenia is still largely unknown or open to different interpretations. The genetic disposition does not always express in twins being the same disorder as cases of one identical twin having schizophrenia and the other having bipolar disorder have been reported.[13]
  • There is currently a great deal of effort being put into molecular genetic studies of schizophrenia, which attempt to identify specific genes which may increase risk. Because of this, the genes that are thought to be most involved can change as new evidence is gathered. A 2003 review of linkage studies listed seven genes as likely to increase risk for a later diagnosis of the disorder.[1] Two more recent reviews[2][14] have suggested that the evidence is currently strongest for two genes known as dysbindin (DTNBP1) and neuregulin (NRG1), with a number of other genes (such as COMT, RGS4, PPP3CC, ZDHHC8, DISC1, and AKT1) showing some early promising results that have not yet been fully replicated.
  • In 2007, British researches have identified seven different genetic variations that are associated with schizophrenia and which all lie within or very near a gene FXYD6.[15][16] A genetic association study of chromosome 11q22-24 in two different samples implicates the FXYD6 gene, encoding phosphohippolin, in susceptibility to schizophrenia. This gene, which lies on the long arm of chromosome 11, plays an important role in regulating Na/K homeostasis.
  • After-conception causes for increase in schizophrenia-rate in a population
    • Lack of sunshine, in the 3rd trimester of gestation ( in the temperate regions a Spring birth, but also El Nino years in Australia, and a particularly overcast 3-month stretch in, IIRC, Brazil, all followed by birth of increased schizophrenia-rate population ).
    • Medical X-Rays, ( IIRC, also in the 3rd trimester of gestation ).
    • Influenza in the mother, during later pregnancy.
    • Older fathers ( poorer-quality genetic contribution )
  • Therefore, it is likely a genetic activation, rather-than simple-possession of specific genes, that is the true cause of it ( simply having the genes would be Required, but Not Sufficient: having 'em activated might be the sufficient bit ).
Emotional
  • A number of emotional factors have been implicated in schizophrenia, with some models putting them at the core of the disorder. It was thought that the appearance of blunted affect meant that sufferers did not experience strong emotions, but more recent studies indicate there is often a normal or even heightened level of emotionality, particularly in response to negative events or stressful social situations.[17]
  • Related studies suggest that the content of delusional and psychotic beliefs in schizophrenia can be meaningful and play a causal or mediating role in reflecting the life history or social circumstances of the individual.[18]
Environmental.
  • Recurrent unexpected panic attacks. Excessive worry about additional panic attack.
Social anxiety disorder.
  • Excessive anxiety about social situations where the individual is worried about scrutiny by others.
Agoraphobia
  • Fear of places or circumstances, where an individual perceives as difficult to escape.
Substance/medication induced anxiety disorder
Selective mutism
  • Failure to speak in certain situations in which there is an expectation for speaking(e.g., school) but is able to speak at home.
Specific phobia
  • Persistent fear of a certain object or situation (e.g., fear of heights, fear of animals).
Anxiety due to another medical condition
  • Fear is due to direct result of a medical condition.
Unspecified anxiety disorder
  • This classification applies to conditions in which anxiety is predominant but do not meet full criteria for any of the disorders in the DSM-5 classification of anxiety disorders.

References

  1. 1.0 1.1 Harrison PJ, Owen MJ. (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet, 361(9355), 417–9. PMID 12573388
  2. 2.0 2.1 Owen MJ, Craddock N, O'Donovan MC. (2005). Schizophrenia: genes at last? Trends in Genetics, 21(9), 518–25. PMID 16009449
  3. Davies G, Welham J, Chant D, Torrey EF, McGrath J. (2003). A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophrenia Bulletin, 29 (3), 587–93. PMID 14609251
  4. Brown, A.S. (2006). Prenatal infection as a risk factor for schizophrenia. Schizophrenia Bulletin, 32 (2), 200–2. PMID 16469941
  5. Hans SL, Marcus J, Nuechterlein KH, et al (1999). Neurobehavioral deficits at adolescence in children at risk for schizophrenia: The Jerusalem Infant Development Study. Arch Gen Psychiatry. 56(8):741–8. PMID 10435609
  6. Carter JW, Schulsinger F, Parnas J, Cannon T, Mednick SA. (2002). A multivariate prediction model of schizophrenia. Schizophrenia Bulletin 28(4):649–82. PMID 12795497
  7. Hans SL, Auerbach JG, Asarnow JR, Styr B, Marcus J. (2000). Social adjustment of adolescents at risk for schizophrenia: the Jerusalem Infant Development Study. J Am Acad Child Adolesc Psychiatry. 39(11):1406–14. PMID 11068896
  8. Dworkin RH, Bernstein G, Kaplansky LM, et al (1991). Social competence and positive and negative symptoms: a longitudinal study of children and adolescents at risk for schizophrenia and affective disorder. Am J Psychiatry. Sep;148(9):1182–8. PMID 1882996
  9. Read J, Perry BD, Moskowitz A, Connolly J (2001). The contribution of early traumatic events to schizophrenia in some patients: a traumagenic neurodevelopmental model. Psychiatry, 64, 319-45. PMID 11822210Full text) (PDF), Retrieved on 2007-05-16
  10. Torrey, E.F., Bowler, A.E., Taylor, E.H. & Gottesman, I. I (1994) Schizophrenia and manic depressive disorder. New York: Basic books. ISBN 0-465-07285-2
  11. Koskenvuo M, Langinvainio H, Kaprio J, Lonnqvist J, Tienari P (1984). Psychiatric hospitalization in twins. Acta Genet Med Gemellol (Roma), 33(2),321–32. PMID 6540965
  12. Hoeffer A, Pollin W. (1970). Schizophrenia in the NAS-NRC panel of 15,909 veteran twin pairs. Archives of General Psychiatry, 1970 Nov; 23(5):469–77. PMID 5478575
  13. Dalby, JT, Morgan D & Lee, M (1986). Schizophrenia and mania in identical twin brothers. Journal of Nervous and Mental Disease 174, 304–308. PMID 3701318
  14. Riley B, Kendler KS (2006). Molecular genetic studies of schizophrenia. Eur J Hum Genet, 14 (6), 669–80. PMID 16721403
  15. Getting Crowded on Chromosome 11q22—Make Way for Phosphohippolin. Schizophrenia Research Forum, 14 March 2007. Retrieved on 2007-05-16
  16. Choudhury K, McQuillin A, Puri V, Pimm J, et al (2007). Am J Hum Genet. Apr;80(4):664-72. PMID 17357072
  17. Cohen & Docherty (2004). Affective reactivity of speech and emotional experience in patients with schizophrenia. Schizophr Res, 1;69(1):7–14. PMID 15145465
  18. Birchwood M, Meaden A, Trower P, Gilbert P, Plaistow J (2000).
    • The power and omnipotence of voices: subordination and entrapment by voices and significant others. Psychol Med. Mar;30(2):337–44. PMID 10824654

Template:WH Template:WS